CN Patent

CN116997323A — 包含利培酮和可生物降解的聚合物的长效可注射制剂

Assigned to Matheson Ag · Expires 2023-11-03 · 3y expired

What this patent protects

本发明涉及治疗精神疾病和精神障碍的方法，包括以不超过每28天一次的频率向有此需要的受试者施用包含利培酮、三嵌段共聚物和二嵌段共聚物的可注射制剂，其中，利培酮的浓度为250‑400mg/mL，注射体积为1mL以下。

USPTO Abstract

本发明涉及治疗精神疾病和精神障碍的方法，包括以不超过每28天一次的频率向有此需要的受试者施用包含利培酮、三嵌段共聚物和二嵌段共聚物的可注射制剂，其中，利培酮的浓度为250‑400mg/mL，注射体积为1mL以下。

Drugs covered by this patent

Patent Metadata

Patent number
CN116997323A
Jurisdiction
CN
Classification
—
Expires
2023-11-03
Drug substance claim
No
Drug product claim
No
Assignee
Matheson Ag
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.